Methylphenidate is a CNS stimulant prescribed to help manage the symptoms of ADHD and narcolepsy. This guide covers methylphenidate uses, how it works, dosage, side effects, precautions, drug interactions, use in pregnancy and breastfeeding and brand names.
What Is Methylphenidate?
Methylphenidate is a CNS stimulant prescribed to help manage symptoms of ADHD and narcolepsy. It does not cure either condition. Brand names include Ritalin and Concerta.
Uses of Methylphenidate
- ADHD: It helps manage symptoms such as poor focus, impulsivity and hyperactivity, in children and adults.
- Narcolepsy: It helps manage excessive daytime sleepiness and sleep attacks.
How Methylphenidate Works
Methylphenidate blocks the reuptake of dopamine and norepinephrine. This leaves more of these brain chemicals available between nerve cells. They are involved in attention, alertness and impulse control.
Methylphenidate Dosage and Administration
The doses below summarize published prescribing information. They are not personal advice. The dose depends on the condition, age, the product and how the person responds, and the doctor adjusts it step by step.
Different methylphenidate products release the drug differently. Standard tablets are taken 2 or 3 times a day. Slow-release products are usually taken once a day. They are not interchangeable milligram for milligram. Stay on the brand your doctor prescribes unless advised otherwise.
UK NHS guidance (reviewed March 2025)
Adults
- Standard tablets: usual start is 5 mg, 2 or 3 times a day. For narcolepsy, treatment usually starts at 10 mg, increasing to a maximum of 20 mg or 30 mg per dose. Total daily doses can sometimes reach 60 mg, split over 2 or 3 doses.
- Slow-release tablets: usual start is 18 mg once a day, increased by 18 mg, usually weekly.
- Slow-release capsules: usual start is 10 mg once a day, increased gradually, usually weekly.
Children
- Standard tablets: usual start is 5 mg once or twice a day, increased usually weekly. A maximum is not stated.
- Slow-release tablets: usual start is 18 mg once a day in the morning, increased in 18 mg steps, with a maximum of 54 mg.
- Slow-release capsules: usual start is 10 mg once a day in the morning, increased gradually, with a maximum of 60 mg.
How to take it (NHS)
- Take standard tablets in the morning, around midday and, if prescribed, in the late afternoon. Leave at least 4 hours between doses. For children, the last dose should be at least 4 hours before bedtime.
- Swallow slow-release tablets whole. Do not crush or break them.
- Some slow-release capsules can be opened onto soft food, and some standard tablets can be crushed into soft food. Check your brand’s leaflet.
- Timing with food depends on the brand. For example, Equasym XL is taken before breakfast and Medikinet XL with or after breakfast.
- Missed dose: skip it and take the next dose at the usual time. Do not take two doses to make up for it.
- Overdose: if more than the prescribed dose is taken, seek medical help straight away (see the emergency section below).
US prescribing information (Ritalin tablets, revised 10/2023)
This applies to immediate-release Ritalin tablets (5, 10 and 20 mg), not to slow-release products.
- Children: start with a low dose twice daily, before breakfast and lunch, increasing weekly in steps of 5–10 mg. Doses above 60 mg a day are not recommended.
- Adults: the average daily dose is 20–30 mg, divided into 2 or 3 doses, preferably 30–45 minutes before meals. The maximum is 60 mg a day.
- Sleep: patients who cannot sleep when a dose is taken late in the day should take the last dose earlier.
- Review of benefit: if there is no improvement after appropriate dose adjustment over about one month, the label says the medicine should be discontinued.
- Age: safety and effectiveness for ADHD have been established in children, but not in younger children below the age stated in the label. Ritalin has not been studied in older adults.
Take this medicine only as advised by your doctor or healthcare professional. Do not start, stop, or change the dose on your own.
Side Effects of Methylphenidate
Common (NHS and US label)
- Headache
- Trouble sleeping
- Reduced appetite and some weight loss, especially early in treatment
- Stomach ache, nausea or vomiting
- Dry mouth
- Fast heartbeat or palpitations, anxiety and heavy sweating (US label)
Less common but important (NHS)
- Mood or personality changes, such as aggression, irritability, low mood or anxiety
- Fast or irregular heartbeat
- Hallucinations
- Facial tics
- A small rise in blood pressure and heart rate, which doctors usually check regularly
Contact your doctor promptly if you notice these.
Get urgent medical help for:
- Thoughts of harming yourself or others
- Chest pain
- Stroke signs (face drooping, one-sided weakness, slurred speech)
- Fits (seizures)
- A painful or prolonged erection
- Signs of a serious allergic reaction, such as swelling of the lips, mouth, throat or tongue, or difficulty breathing
In India, call 112 (the single national emergency number) or go to the nearest hospital. The UK NHS advises 999 or 111, which do not apply in India. Do not drive yourself if you are unwell. Take the medicine packet with you.
Methylphenidate Abuse, Misuse and Addiction (Boxed Warning)
The US label carries a boxed warning for abuse, misuse and addiction. Methylphenidate has a high potential for abuse and misuse, which can lead to substance use disorder, including addiction. Misuse can cause overdose and death, and the risk rises with higher doses and with unapproved routes of use. Doctors assess this risk before prescribing and monitor throughout treatment.
- Take it exactly as prescribed.
- Never share or sell your medicine.
- Store it safely, out of reach of others.
- Tell your doctor if you have had problems with drugs or alcohol.
Methylphenidate Contraindications and Precautions
Contraindications (US Ritalin label)
- Known hypersensitivity to methylphenidate or any component of the product. Angioedema and anaphylaxis have been reported.
- Use with an MAO inhibitor, or within 14 days of stopping one, because of the risk of a hypertensive crisis (a dangerous spike in blood pressure).
Precautions (extra care or monitoring)
- Heart conditions: sudden death has been reported in people with structural heart abnormalities or other serious heart disease, and the label advises avoiding use in these patients. Blood pressure and heart rate can rise, so doctors monitor them.
- Mental health: it can worsen psychosis or trigger mania or new psychotic symptoms. Doctors screen for risk before starting.
- Tics and Tourette’s syndrome: tics may start or worsen. Tell your doctor about any family history.
- Eyes: acute angle-closure glaucoma and raised eye pressure have been reported. Tell your doctor if you have glaucoma or are at risk.
- Fingers and toes: peripheral vasculopathy, including Raynaud’s phenomenon, can occur. Report colour changes or pain.
- Priapism: prolonged or painful erections are a medical emergency.
- Growth in children: weight loss and slowed growth have been reported, so height and weight are monitored.
- Other conditions to mention (NHS): an overactive thyroid, adrenal gland tumour (phaeochromocytoma), high blood pressure, blood vessel problems such as vasculitis, epilepsy, difficulty swallowing, and past problems with drugs or alcohol.
Methylphenidate Drug Interactions
- MAO inhibitors: must not be used together or within 14 days of each other.
- Blood pressure medicines: methylphenidate may reduce their effect. Blood pressure may need monitoring.
- Halogenated anaesthetics: the US label advises avoiding methylphenidate on the day of planned surgery that uses these anaesthetics, because of a risk of sudden blood pressure and heart rate rises.
- Risperidone: changing the dose of either medicine may raise the risk of movement-related side effects. Doctors monitor for these.
Tell your doctor or pharmacist about all prescription and OTC medicines, supplements and herbal products you use. This list is not complete.
Methylphenidate in Pregnancy, Breastfeeding and Fertility
- Pregnancy: the NHS says methylphenidate is not often used in pregnancy because safety information is limited. The US label states that published studies and reports have not identified a drug-associated risk of major birth defects or miscarriage. Animal studies showed effects at high doses. This does not prove the medicine is safe. Do not stop or change treatment on your own. Discuss the benefits and risks with your doctor.
- Breastfeeding: methylphenidate passes into breast milk in small amounts. The US label reports no adverse effects in breastfed infants in the limited data available. The NHS advises watching for poor feeding, weight concerns, irritability, sleep problems, sickness, diarrhoea or rash, and contacting a healthcare professional if these occur.
- Fertility: the NHS states there is no evidence that methylphenidate affects fertility.
Methylphenidate Brands and Availability in India
Brand | Strength and form | Marketer (as listed) |
Inspiral | 5 mg and 10 mg tablets | Ipca Laboratories |
Concerta | 18 mg extended-release tablet | Janssen (listed by an importer/supplier) |
Pharmacy and supplier listings do not prove regulatory approval or nationwide availability, and the listings did not show a reliable MRP or pack size. Availability and price vary by pharmacy and location. This medicine is available only on prescription.
How HealthPil Can Help
Medicines should be started, adjusted, or stopped only under the guidance of a qualified healthcare professional. If you have questions about this medicine, its side effects, or your treatment plan, you can consult a doctor through HealthPil.
FAQ
How long does Methylphenidate take to work?
Can Methylphenidate cause weight loss?
Is Methylphenidate safe for children?
Is methylphenidate addictive?
It has a boxed warning for abuse, misuse and addiction. Taking it exactly as prescribed and never sharing it reduces the risk.
Does methylphenidate cure ADHD?
No. It helps manage symptoms while it is being taken.
References
Drugs.com. Methylphenidate: Uses, Dosage, Side Effects, and Warnings. Available at:
Drugs.comNHS. Methylphenidate for adults. Available at:
NHSPubMed. Article indexed in PubMed (PMID: 29494058). Available at:
PubMed
Disclaimer:
Methylphenidate should be used cautiously in patients with heart conditions and mental health disorders due to potential side effects.
Read our editorial policy